This action will enable patients currently enrolled in the Assist-3 and Assist-5 trials the opportunity to continue to receive study treatments, including Telcyta in combination with chemotherapy, subject
Bupropion hydrochloride extended-release is the generic equivalent to GlaxoSmithKline’s Wellbutrin XL tablets, which is indicated for the treatment of major depressive disorder. The company intends to launch the
Scientists at Dana-Farber Cancer Institute in collaboration with researchers at Brigham and Women’s Hospital and the Broad Institute of Harvard and MIT, found that unlike breast cancer-susceptibility genes
Sanofi Pasteur was given $77.4 million, while MedImmune’s contract was approximately $55.1 million. According to Reuters, the government is keen to get vaccine factories up and running in
A total of 56 patients will be enrolled in the study which is being conducted under Genmab’s collaboration with GlaxoSmithKline. Patients in this open label study will be
In the 623-patient study, 58.5% of patients receiving the combination of Actemra (8mg/kg) and methotrexate achieved at least a 20% improvement in rheumatoid arthritis (RA) symptoms compared with
The study results appear in the June edition of Cancer Research, a journal published by the American Association of Cancer Research. The authors describe results showing that Azixa
The Icelandic biotech drug developer had filed the suit in the US District Court in Philadelphia in an attempt to stop former employees and the hospital from using
The US-based subsidiary of Solvay Group is also seeking an additional indication for AndroGel in the treatment of constitutional delay in growth and puberty (CDGP) in male adolescents.
This represents the first honey-based product to be cleared for medical use in North America. Active Manuka honey-based products have been available throughout Europe, Australia, and New Zealand
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.